
Home » Novartis’ Ultibro Breezhaler Reduces COPD Symptoms, Improves Lung Function
Novartis’ Ultibro Breezhaler Reduces COPD Symptoms, Improves Lung Function

December 8, 2016
Novartis’ dual bronchodilator, Ultibro Breezhaler, showed improvements in lung function and a reduction in chronic obstructive pulmonary disease symptoms.
The study has provided further support to limit the use of inhaled steroid-containing therapies, the company said.
The combination device is approved for use in more than 90 countries. — Cynthia Jessup
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr